Company news

Sight Sciences, Inc. news in 2025

Sight Sciences, Inc.'s news releases, calls and decks from 2025, newest first.

View company

New Peer-Reviewed Publications Highlight Effectiveness of OMNI® Surgical System with TruSync™ Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans

November 11, 2025

Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance

November 6, 2025

Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer

November 6, 2025

Sight Sciences to Present at Two Upcoming Investor Conferences

November 4, 2025

Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025

October 23, 2025

Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye Procedure

October 17, 2025

Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use

September 17, 2025

Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments

September 9, 2025

Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO

September 2, 2025

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

August 26, 2025

Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance

August 7, 2025

Sight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare® System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated Dry Eye Disease

July 30, 2025

Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye Disease

July 29, 2025

Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025

July 24, 2025

Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th

May 14, 2025

Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

May 8, 2025

Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025

April 24, 2025

Sight Sciences Announces the Release of its Sustainability Report

April 23, 2025

Sight Sciences Appoints Gary Burbach to its Board of Directors

April 22, 2025

Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio

April 21, 2025

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th

March 25, 2025

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance

March 5, 2025

Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting

February 24, 2025

Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025

February 19, 2025

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

January 13, 2025

Sight Sciences Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System in Managing Primary Open-Angle Glaucoma

January 6, 2025

Calls in 2025

Decks in 2025